MedPath

A double blind randomised placebo controlled clinical trial for evaluating the efficacy of Eranda Patra Kshara and Hingu churna with lifestyle modification in the management of Non-alcoholic fatty liver disease

Phase 3
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2023/04/052096
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Non-alcoholic fatty liver disease

Exclusion Criteria

1.The ratio of AST/ALT over 2

2.Metabolic syndrom such as uncontrolled Type 1 and Type 2 diabetes mellitus,hypertension

3.Thyroid dysfunction hyperthyroidism or hypothyroidism.

4.Alcoholic fatty liver disease patient

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath